Log in to save to my catalogue

Maternal immunization against Group B streptococcus: World Health Organization research and developm...

Maternal immunization against Group B streptococcus: World Health Organization research and developm...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6892248

Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics

About this item

Full title

Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2019-11, Vol.37 (50), p.7391-7393

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

AbstractGroup B streptococcus, found in the vagina or lower gastrointestinal tract of about 10–40% of women of reproductive age, is a leading cause of early life invasive bacterial disease, potentially amenable to prevention through maternal immunization during pregnancy. Following a consultation process with global stakeholders, the World Health O...

Alternative Titles

Full title

Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6892248

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6892248

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2017.09.087

How to access this item